Patents by Inventor David R. McGee
David R. McGee has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20160266871Abstract: A multimodal system using at least one speech recognizer to perform speech recognition utilizing a circular buffer to unify all modal events into a single interpretation of the user's intent.Type: ApplicationFiled: March 11, 2016Publication date: September 15, 2016Inventors: Phillipp H. Schmid, David R. McGee
-
Publication number: 20120054601Abstract: Methods, techniques, and systems for icon automated generation and placement are provided. Some embodiments provide an icon generation and placement system configured to ingest one or more icon templates, wherein the icon templates comprise an icon symbol, an icon label, and an icon dimensionality; populate source data for the one or more icon templates, wherein the source data is accessible by at least one of a speech recognition subsystem, handwriting recognition subsystem, and sketch recognition subsystem; generate an icon attribute table for the one or more icon templates; store the ingested one or more icon templates in an icon database; and place an icon, from the icon database into a selected location within a digital document in response to one or more multimodal inputs.Type: ApplicationFiled: May 31, 2011Publication date: March 1, 2012Applicant: ADAPX, INC.Inventors: Philip R. Cohen, R. Matthews Wesson, Michael Robin, David R. McGee
-
Patent number: 6674426Abstract: A method and system designed to augment, rather than replace, the work habits of its users. These work habits include practices such as drawing on Post-it™ notes using a symbolic language. The system observes and understands the language used on the Post-it notes and the system assigns meaning simultaneously to objects in both the physical and virtual worlds. Since the data is preserved in physical form, the physical documents serve as a back-up in the case of electronic system failure. With the present invention users can rollout a primary paper document such as a map, register it, and place secondary physical documents on the map. The secondary physical documents can be moved from one place to another on the primary document. Once an object is augmented, users can modify the meaning represented by it, ask questions about that representation, view it in virtual reality, or give directions to it, all with speech and gestures.Type: GrantFiled: March 8, 2001Date of Patent: January 6, 2004Assignee: Oregon Health & Science UniversityInventors: David R. McGee, Philip R. Cohen, Lizhong Wu
-
Publication number: 20030167512Abstract: The present invention provides a method of compiling a plant positive sense functional gene profile, a method of changing the phenotype or biochemistry of a plant, a method of determining a change in phenotype or biochemistry of a plant, and a method of determining the presence of a trait in plant. The methods comprise expressing transiently a nucleic acid sequence of a plant into the cytoplasm of a host plant in a plus sense orientation to affect phenotypic or biochemical changes in the host plant. The nucleic acid sequence does not need to be isolated, identified or characterized prior to transfection into the host plant. A viral vector functional genomic screen has been developed to identify nucleotide sequences in transfected plants by systemically overproducing a new protein, or enhancing or suppressing the endogenous gene expression in a plus sense mechanism.Type: ApplicationFiled: September 6, 2002Publication date: September 4, 2003Inventors: Monto H. Kumagai, Guy R. Della-Cioppa, Robert L. Erwin, David R. McGee
-
Publication number: 20030077619Abstract: The present invention provides a method of compiling a functional gene profile of an organism, a method of changing the phenotype or biochemistry of a plant, a method of determining a change in phenotype or biochemistry of a plant, a method of determining the presence of a trait in plant, and a method of isolating human cDNA. The methods comprise expressing transiently a nucleic acid sequence of a non-plant donor organism into a host plant by a viral vector to affect phenotypic or biochemical changes in the host plant. The present invention provides a method for discovering the presence of a new gene and determining its function and sequence in a donor organism such as human by transfecting a nucleic acid sequence of the donor organism into a host plant to knock out the endogenous gene expression.Type: ApplicationFiled: May 8, 2002Publication date: April 24, 2003Inventors: Monto H. Kumagai, Guy R. della-Cioppa, Robert L. Erwin, David R. McGee
-
Publication number: 20030064392Abstract: The present invention provides a method of compiling a functional gene profile of an organism, a method of changing the phenotype or biochemistry of a plant, a method of determining a change in phenotype or biochemistry of a plant, a method of determining the presence of a trait in plant, and a method of humanizing plant cDNA. The methods comprise expressing transiently a nucleic acid sequence of a non-plant donor organism into a host plant by a viral vector to affect phenotypic or biochemical changes in the host plant. The present invention provides a method for discovering the presence of a new gene and determining its function and sequence in a donor organism such as human by transfecting a nucleic acid sequence of the donor organism into a host plant to knock out the endogenous gene expression.Type: ApplicationFiled: May 22, 2002Publication date: April 3, 2003Inventors: Monto H. Kumagai, Guy R. della-Cioppa, Robert L. Erwin, David R. McGee
-
Publication number: 20030041355Abstract: The present invention provides a method of compiling a positive sense functional gene profile of an organism, a method of changing the phenotype or biochemistry of an organism, a method of determining the presence of a trait in an organism, and a method of humanizing a plant cDNA. The methods comprise expressing transiently a nucleic acid sequence of a donor organism into a host plant to affect phenotypic or biochemical changes in the host organism. Once the presence of a trait in a plant is identified by phenotypic or biochemical changes in the host plant, the nucleic acid insert in the cDNA clone or in the vector that results in the changes is then sequenced. The present invention provides a method for discovering new gene and its function in a donor organism such as human by transfecting a nucleic acid sequence of the donor organism into a host organism in a positive sense.Type: ApplicationFiled: May 14, 2002Publication date: February 27, 2003Inventors: Monto H. Kumagai, Guy R. della-Cioppa, Robert L. Erwin, David R. McGee
-
Publication number: 20030028926Abstract: The present invention provides a method of compiling a positive sense functional gene profile of an organism, a method of changing the phenotype or biochemistry of an organism, a method of determining a change in phenotype or biochemistry of an organism, and a method of determining the presence of a trait in an organism, and a method of isolating human cDNA. The methods comprise expressing transiently a nucleic acid sequence of a donor organism into a host plant to affect phenotypic or biochemical changes in the host organism. A viral vector functional genomic screen has been developed to identify nucleotide sequences in transfected plants by enhancing or supressing an endogenous gene expression in a positive sense mechanism, or by overexpressing a new protein. Once the presence of a trait in a plant is identified by phenotypic or biochemical changes in the host plant, the nucleic acid insert in the cDNA clone or in the vector that results in the changes is then sequenced.Type: ApplicationFiled: May 1, 2002Publication date: February 6, 2003Inventors: Monto H. Kumagai, Guy R. della-Cioppa, Robert L. Erwin, David R. McGee
-
Publication number: 20030027182Abstract: The present invention provides a method of compiling a plant functional gene profile, a method of changing the phenotype or biochemistry of a plant, a method of determining a change in phenotype or biochemistry of a plant, and a method of determining the presence of a trait in plant. The methods comprise expressing transiently a nucleic acid sequence of a plant into a host plant to affect phenotypic or biochemical changes in the host plant. A viral vector functional genomic screen has been developed to identify nucleotide sequences in transfected plants by systemically knocking out endogenous gene expression in an antisense mechanism. Once the presence of a trait in a plant is identified by phenotypic or biochemical changes in the host plant, the nucleic acid insert in the cDNA clone or in the vector that results in the changes is then sequenced. The present invention exemplifies that genes encoding GTP binding proteins in one plant can silence endogenous gene expression in a different plant.Type: ApplicationFiled: March 21, 2002Publication date: February 6, 2003Inventors: Monto H. Kumagai, Guy R. Della-Cioppa, Robert L. Erwin, David R. McGee
-
Publication number: 20030027183Abstract: The present invention provides a method of compiling a plant functional gene profile, a method of changing the phenotype or biochemistry of a plant, a method of determining a change in phenotype or biochemistry of a plant, and a method of determining the presence of a trait in plant. The methods comprise expressing transiently a nucleic acid sequence of a plant into a host plant to affect phenotypic or biochemical changes in the host plant. A viral vector functional genomic screen has been developed to identify nucleotide sequences in transfected plants by systemically knocking out endogenous gene expression in an antisense mechanism. Once the presence of a trait in a plant is identified by phenotypic or biochemical changes in the host plant, the nucleic acid insert in the cDNA clone or in the vector that results in the changes is then sequenced. The present invention exemplifies that genes encoding GTP binding proteins in one plant can silence endogenous gene expression in a different plant.Type: ApplicationFiled: April 10, 2002Publication date: February 6, 2003Inventors: Monto H. Kumagai, Guy R. della-Cioppa, Robert L. Erwin, David R. McGee
-
Publication number: 20030027173Abstract: The present invention provides methods for rapidly determining the function of nucleic acid sequences by transfecting the same into a host organism to effect expression. Phenotypic and biochemical changes produced thereby are then analyzed to ascertain the function of the nucleic acids which have been transfected into the host organism. The invention also provides methods for silencing endogenous genes by transfecting hosts with nucleic acid sequences to effect expression of the same. The present invention also provides methods for selecting desired functions of RNAs and proteins by the use of virus vectors to express libraries of nucleic acid sequence variants. Moreover, the present invention provides methods for inhibiting an endogenous protease of a plant host.Type: ApplicationFiled: February 5, 2002Publication date: February 6, 2003Inventors: Guy Della-Cioppa, Robert L. Erwin, Wayne P. Fitzmaurice, Kathleen Hanley, Monto H. Kumagai, John A. Lindbo, David R. McGee, Hal S. Padgett, Gregory P. Pogue
-
Publication number: 20030024008Abstract: The present invention provides a method of compiling a plant functional gene profile, a method of changing the phenotype or biochemistry of a plant, a method of determining a change in phenotype or biochemistry of a plant, a method of determining the presence of a trait in plant, and a method of increasing grain crop. The methods comprise expressing transiently a nucleic acid sequence of a plant into a host plant to affect phenotypic or biochemical changes in the host plant. A viral vector functional genomic screen has been developed to identify nucleotide sequences in transfected plants by systemically knocking out endogenous gene expression in an antisense mechanism. Once the presence of a trait in a plant is identified by phenotypic or biochemical changes in the host plant, the nucleic acid insert in the cDNA clone or in the vector that results in the changes is then sequenced.Type: ApplicationFiled: April 24, 2002Publication date: January 30, 2003Inventors: Monto H. Kumagai, Guy R. Della-Cioppa, Robert L. Erwin, David R. McGee
-
Patent number: 6426185Abstract: The present invention provides a method of compiling a plant functional gene profile, a method of changing the phenotype or biochemistry of a plant, a method of determining a change in phenotype or biochemistry of a plant, and a method of determining the presence of a trait in plant. The methods comprise expressing transiently a nucleic acid sequence of a plant into a host plant to affect phenotypic or biochemical changes in the host plant. A viral vector functional genomic screen has been developed to identify nucleotide sequences in transfected plants by systemically knocking out endogenous gene expression in an antisense mechanism. Once the presence of a trait in a plant is identified by phenotypic or biochemical changes in the host plant, the nucleic acid insert in the cDNA clone or in the vector that results in the changes is then sequenced. The present invention exemplifies that genes encoding GTP binding proteins in one plant can silence endogenous gene expression in a different plant.Type: GrantFiled: July 21, 1999Date of Patent: July 30, 2002Assignee: Large Scale Biology CorporationInventors: Monto H. Kumagai, Guy R. della-Cioppa, Robert L. Erwin, David R. McGee
-
Patent number: 5817631Abstract: The invention is directed to the treatment of degenerative diseases of tissues which have lost melanin and which share a common embryological basis as tissues of the nervous system by the administration of an active substance which causes an increased concentration of melanin in the tissue. Such active substances include melanin, melanin variants, melanin analogs, melanin derivatives, tyrosinase, tyrosinase gene, melanin-concentrating hormone and combinations thereof. Examples of such diseases include Parkinson's disease, Alzheimer's disease, retinitis pigmentosa, schizophrenia and dementia. The invention is also useful in assisting in the repair of neurons in a mammal having neuron damage by administering an effective amount of an active substance which causes an increased concentration of melanin in the neuron to aid in nerve repair.Type: GrantFiled: June 6, 1995Date of Patent: October 6, 1998Assignee: Biosource Technologies, Inc.Inventors: David L. Berliner, Robert L. Erwin, David R. McGee
-
Patent number: 5776968Abstract: The invention is directed to the treatment of degenerative diseases of tissues which have lost melanin and which share a common embryological basis as tissues of the nervous system by the administration of an active substance which causes an increased concentration of melanin in the tissue. Such active substances include melanin, melanin variants, melanin analogs, melanin derivatives, tyrosinase, tyrosinase gene, melanin-concentrating hormone and combinations thereof. Examples of such diseases include Parkinson's disease, Alzheimer's disease, retinitis pigmentosa, schizophrenia and dementia. The invention is also useful in assisting in the repair of neurons in a mammal having neuron damage by administering an effective amount of an active substance which causes an increased concentration of melanin in the neuron to aid in nerve repair.Type: GrantFiled: June 7, 1995Date of Patent: July 7, 1998Assignee: Biosource Technologies, Inc.Inventors: David L. Berliner, Robert L. Erwin, David R. McGee
-
Patent number: 5703051Abstract: The invention is directed to the treatment of degenerative diseases of tissues which have lost melanin and which share a common embryological basis as tissues of the nervous system by the administration of an active substance which causes an increased concentration of melanin in the tissue. Such active substances include melanin, melanin variants, melanin analogs, melanin derivatives, tyrosinase, tyrosinase gene, melanin-concentrating hormone and combinations thereof. Examples of such diseases include Parkinson's disease, Alzheimer's disease, retinitis pigmentosa, schizophrenia and dementia. The invention is also useful in assisting in the repair of neurons in a mammal having neuron damage by administering an effective amount of an active substance which causes an increased concentration of melanin in the neuron to aid in nerve repair.Type: GrantFiled: December 10, 1992Date of Patent: December 30, 1997Assignee: Biosource Technologies, Inc.Inventors: David L Berliner, Robert L. Erwin, David R. McGee
-
Patent number: 5210076Abstract: The invention is directed to the treatment of degenerative diseases of tissues which have lost melanin and which share a common embryological basis as tissues of the nervous system by the administration of an active substance which causes an increased concentration of melanin in the tissue. Such active substances include melanin, melanin variants, melanin analogs, melanin derivatives, tyrosinase, tyrosinase gene, melanin-concentrating hormone and combinations thereof. Examples. of such diseases include Parkinson's disease, Alzheimer's disease, retinitis pigmentosa, schizophrenia and dementia. The invention is also useful in assisting in the repair of neurons in a mammal having neuron damage by administering an effective amount of an active substance which causes an increased concentration of melanin in the neuron to aid in nerve repair.Type: GrantFiled: November 5, 1990Date of Patent: May 11, 1993Inventors: David L. Berliner, Robert L. Erwin, David R. McGee